Elevated systemic biomarkers and persistent anxiety and depression in smokers with and without COPD: An analysis of the SPIROMICS cohort

V. Kim (Philadelphia, United States of America)

Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies?
Session: What is new in COPD management and prognosis: findings from large studies?
Session type: Poster Discussion
Number: 4967
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Kim (Philadelphia, United States of America). Elevated systemic biomarkers and persistent anxiety and depression in smokers with and without COPD: An analysis of the SPIROMICS cohort. 4967

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
High prevalence of current smokers among COPD patients with anxiety and depression symptoms
Source: Eur Respir J 2001; 18: Suppl. 33, 193s
Year: 2001

Smoking status and levels of anxiety and depression in hospitalized patients.
Source: International Congress 2018 – Effect of tobacco use on health
Year: 2018

The relationship between persistent systemic inflammation and symptoms of depression among patients with COPD in the ECLIPSE cohort
Source: Annual Congress 2013 –The best abstracts in extra-pulmonary features and pulmonary rehabilitation
Year: 2013

The correlation between depression and anxiety and pulmonary function in COPD patients
Source: Annual Congress 2010 - Comorbidities and disease management in primary care
Year: 2010


Positive association between the plasma levels of 5-hydroxyindoleacetic acid and the severity of depression in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013

Prevalence of anxiety and depression in COPD: are females at higher risk?
Source: Eur Respir J 2005; 26: Suppl. 49, 514s
Year: 2005

The role of evaluation of anxiety and depression in hospitalized asthma patients
Source: Annual Congress 2004 - Asthma and perceived health status
Year: 2004


Comparing the prevalence of depression and anxiety in patients admitted with an exacerbation of COPD using two scoring systems
Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations
Year: 2015


Effect of depression and anxiety on the risk of exacerbation and hospitalization in COPD
Source: Annual Congress 2008 - Epidemiology of respiratory symptoms and COPD
Year: 2008

Smoking, anxiety and depression in relation to chronic respiratory diseases: results of population survey ROSEPID
Source: Annual Congress 2009 - Tobacco, bronchial tubes and the lung
Year: 2009


Quantification of smokers and smoking status among COPD patients, hospitalized for an exacerbation
Source: Annual Congress 2011 - Challenges in rehabilitation: some old dilemmas revisited with some solutions?
Year: 2011


Proteomic analysis of plasma from COPD patients and smoking control subjects
Source: Annual Congress 2007 - Novel therapeutic targets and disease markers in pulmonary pathology
Year: 2007



Determinants of anxiety and depression among Filipino patients with chronic obstructive pulmonary disease: A multi-center study
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013

Relationship between depression and exacerbations in COPD: a response
Source: Eur Respir J 2008; 32: 1126-1127
Year: 2008


Relationship between respiratory symptoms (and diagnosis), anxiety or depression and smoking cigarettes: a population-based study
Source: Eur Respir J 2002; 20: Suppl. 38, 178s
Year: 2002

The impact of depressive symptoms on recovery and outcome of hospitalised COPD exacerbations
Source: Eur Respir J 2013; 41: 815-823
Year: 2013



The effects of anxiety and depression on treatment adherence in COPD patients
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010


Impact of pulmonary rehabilitation on anxiety and depression in patients with COPD
Source: Annual Congress 2008 - Impact of rehabilitation programmes in COPD and non-COPD patients
Year: 2008

Serum uric acid levels and uric acid/creatinine ratio in stable COPD patients: Are these parameters efficiently predict risky patients for exacerbation and/or severity of the disease?
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016

Prevalence of anxiety and depression in 196 patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2012 - COPD comorbidities I
Year: 2012